Citation Impact
Citing Papers
The ROR nuclear orphan receptor subfamily: Critical regulators of multiple biological processes
2001
Lysyl Oxidase Binds Transforming Growth Factor-; and Regulates Its Signaling via Amine Oxidase Activity
2008
Diphenyleneiodium Chloride Blocks Inflammatory Cytokine-Induced Up-Regulation of Group IIA Phospholipase A2 in Rat Mesangial Cells
2000
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
1994 StandoutNature
Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes
2005 StandoutNobel
Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells
1990
In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit
1989
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells
1994
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents
2003
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor
2004 StandoutNobel
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
Phospholipase A2 expression in tumours: a target for therapeutic intervention?
2003
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
Isolation and characterisation of a human calcitonin‐gene‐related‐peptide receptor
1987
Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients
1991
Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur
2002
High serum procalcitonin concentrations in patients with sepsis and infection
1993 Standout
Inhibition of Ca2+‐independent phospholipase A2 by bromoenol lactone attenuates prostaglandin generation induced by interleukin‐1β and dibutyryl cAMP in rat mesangial cells
1998
Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine
1995 Standout
Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells
1996
The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression
1997 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Skeletal remodeling in health and disease
2007 Standout
Phospholipase A2 — a mediator between proximal and distal effectors of inflammation
1991
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
1994 StandoutNature
Transcription factor-κB (NF-κB) and renal disease
2001
Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
1992
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP
1994
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
Hypoprolactinemic effect of calcitonin gene-related peptide in the rat
1990
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Sickle-cell disease
2010 Standout
Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2
2000 Standout
Molecular biology of erythropoietin
1993 StandoutNobel
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Tumor Necrosis Factor-α Inversely Regulates Prostaglandin D2 and Prostaglandin E2 Production in Murine Macrophages
1997
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Transforming growth factor β2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells
1991
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Isoforms of nitric oxide synthase Characterization and purification from different cell types
1991 StandoutNobel
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Phospholipase A2 enzymes
2002
cPLA2 is phosphorylated and activated by MAP kinase
1993 Standout
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
1998 StandoutNature
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
2002
Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates.
1990
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Orphan Nuclear Receptors: From Gene to Function*
1999
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Regulation of low shear flow-induced HAEC VCAM-1 expression and monocyte adhesion
1999
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
2001 Standout
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Phospholipase A2 levels in acute chest syndrome of sickle cell disease
1996
Understanding Adipocyte Differentiation
1998 Standout
Mechanisms of Estrogen Action
2001 Standout
Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells.
2000
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
Tumor necrosis factor in the heart
1998
Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts.
1992
Mammalian non-pancreatic phospholipases A2
1993
Diversity of group types, regulation, and function of phospholipase A2.
1994 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.
1993 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Mechanisms of Diabetic Complications
2013 Standout
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
1999 Standout
Regulation of Vascular Smooth Muscle Soluble Guanylate Cyclase Activity, mRNA, and Protein Levels by cAMP-Elevating Agents
1995 StandoutNobel
The Molecular Biology of Axon Guidance
1996 StandoutScience
Segregated Coupling of Phospholipases A2, Cyclooxygenases, and Terminal Prostanoid Synthases in Different Phases of Prostanoid Biosynthesis in Rat Peritoneal Macrophages
1998
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Increased Lipolysis and Decreased Leptin Production by Human Omental as Compared With Subcutaneous Preadipocytes
2002
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Flow-mediated endothelial mechanotransduction
1995 Standout
The mitogen-activated protein kinase signal transduction pathway
1993 Standout
Works of W. Pignat being referenced
Pyrrolidine dithiocarbamate differentially affects cytokine‐ and cAMP‐induced expression of group II phospholipase A2 in rat renal mesangial cells
1995
Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1β- and cAMP-induced group II phospholipase A2 expression in rat renal mesangial cells
1998
PDGF suppresses the activation of group II phospholipase A2gene expression by interleukin I and forskolin in mesangial cells
1991
Cytokine regulation of Group II phospholipase A2 expression in glomerular mesangial cells
1993
Suppression by cyclosporin A of interleukin 1β‐induced expression of group II phospholipase A2 in rat renal mesangial cells
1997
Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells
1989
Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP
1989
Transforming growth factors type‐β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin‐1 and forskolin in rat mesangial cells
1992
Specific Activation of the Nuclear Receptors PPARγ and RORA by the Antidiabetic Thiazolidinedione BRL 49653 and the Antiarthritic Thiazolidinedione Derivative CGP 52608
1998
Evaluation of thein Vivoandin VitroCalcium Regulating Actions of Noncalcitonin Peptides Produced via Calcitonin Gene Expression*
1986
Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.
1998
Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells
1991
Transforming growth factor β2 differentially modulates interleukin-1 β- and tumour-necrosis-factor-α-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells
1990
Susceptibility of interleukin 1- and tumour necrosis factor-induced prostaglandin E2 and phospholipase A2 release from rat renal mesangial cells to different drugs
1989